Article

Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry.
Wasilewski, D., Eitner, C., Ates, R., Murad, S., Shaked, Z., Steinle, J.A., Wetzel-Yalelis, A., Sargut, T.A., Rösler, J., Samman, M.A., Truckenmüller, P., Mertens, R., Kroneberg, D., Kowski, A., Radbruch, H. ORCID: https://orcid.org/0000-0001-6941-3397, Capper, D., Ehret, F., Roohani, S., Frost, N., Nawabi, J., Onken, J., Schlaak, M., Blohmer, J.U., Pelzer, U., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Sehouli, J., Vajkoczy, P., Keilholz, U. and Misch, M.
Journal of Neuro-Oncology 175 (3): 943-965. December 2025

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group.
Hubertus, Vanessa, Viezens, Lennart, Stangenberg, Martin, Früh, Anton M., Meyer, Hanno S., Liang, Raimunde, Kramer, Andreas, Orban, Christoph, Kerschbaumer, Johannes, Kunze, Beate, Telera, Stefano, Miller, Hannah, Entenmann, Christian J., von Bronewski, Emily J., Buhre, Charlotte, Leonhardt, Leon-Gordian, Willenbacher, Wolfgang, Kvitsaridze, Irma, Laue, Dominik, Pumberger, Matthias, Keller, Theresa, Acker, Güliz, Krönke, Jan, Blau, Igor-Wolfgang, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Ringel, Florian, Thomé, Claudius, Meyer, Bernhard, Vajkoczy, Peter, Dreimann, Marc and Onken, Julia Sophie
Journal of Neuro-Oncology 174 (3): 765-777. September 2025

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.
Weller, J. ORCID: https://orcid.org/0000-0001-5818-5392, Schäfer, N., Schaub, C., Tzaridis, T. ORCID: https://orcid.org/0000-0001-9651-1144, Zeyen, T., Schneider, M. ORCID: https://orcid.org/0000-0002-6025-7479, Potthoff, A.L. ORCID: https://orcid.org/0000-0002-5710-6557, Giordano, F.A., Steinbach, J.P., Zeiner, P.S., Kowalski, T., Sabel, M., Hau, P., Krex, D., Grauer, O., Goldbrunner, R., Schnell, O., Tabatabai, G. ORCID: https://orcid.org/0000-0002-3542-8782, Ringel, F. ORCID: https://orcid.org/0000-0003-3132-7543, Schmidt-Graf, F., Brehmer, S., Tonn, J.C., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Vajkoczy, P., Glas, M., Vatter, H., Herrlinger, U. and Seidel, C.
Journal of Neuro-Oncology 161 (1): 147-153. January 2023

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.
Milde, T., Lodrini, M., Savelyeva, L., Korshunov, A., Kool, M., Brueckner, L.M., Antunes, A.S.L.M., Oehme, I., Pekrun, A., Pfister, S.M., Kulozik, A.E., Witt, O. and Deubzer, H.E. ORCID: https://orcid.org/0000-0002-6115-4893
Journal of Neuro-Oncology 110 (3): 335-348. December 2012

Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma - Clinical observations.
von Eckardstein, K.L., Reszka, R. and Kiwit, J.C.W.
Journal of Neuro-Oncology 74 (3): 305-309. 1 September 2005

Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases.
von Eckardstein, K.L., Patt, S., Kratzel, C., Kiwit, J.C.W. and Reszka, R.
Journal of Neuro-Oncology 72 (3): 209-215. 1 January 2005